Abstract
Objective: To evaluate the therapeutic approach to melasma during pregnancy. Bibliographic review: the elevation of progesterone and estrogen during pregnancy increases the expression of melanogenic enzymes, associated with the appearance of melasma. Although melasma cannot be cured, the use of broad-spectrum sunscreens and not excessive exposure to the sun are important preventive measures. During prenatal care, the theme ends up being ignored by the health team, as they focus on other issues of pregnancy, due to the high costs of topical treatments and because it is low in severity, yet melasma interferes with quality of life, as it can cause low self-esteem and sadness. Its treatment slows down the proliferation of melanocytes and promotes the degradation of melanosomes, however, it has limited indication in pregnancy since these spots can disappear up to one year after delivery. However, when performed, the use of topical medications capable of acting in the clearing of melanin, blocking melanocytic function and eliminating melanocytes is prescribed. Final considerations: Since hormonal changes during pregnancy are closely related to the onset of melasma, further studies are needed to ensure comprehensive care for women's health during this period.